What Is Precigen, Inc. (PGEN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Precigen, Inc.'s intrinsic value is estimated at $2.41. Trading at its current price of $5.12, the valuation engine raises significant caution: 3 of 4 models flag downside risk, projecting an average implied return of -53.0%. Notably, PWERM sees the most upside at +12.4% (fair value: $5.76), while Dynamic NAV is the most conservative at -92.6% ($0.38). The spread between these extremes — +105.0% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About PGEN?
4 of 13 models are currently active for PGEN. Of these, 1 model suggests upside while 3 models suggest overvaluation. The Bayesian DCF estimates PGEN's intrinsic value at $1.58, implying -69.1% downside from the current price. See which stocks rank higher →
How Does PGEN Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, PGEN ranks #296 by Quality of Company score. CirclFi's QOC score of 4.4/10 evaluates 32 fundamental signals. A score of 4.4 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Precigen, Inc.'s positioning within the Pharmaceutical Preparations segment means that patent cliff exposure plays an outsized role in fundamental analysis. The sector's unique characteristics — including late-stage pipeline catalysts — shape both the opportunity set and risk profile.
Is PGEN a Value Trap?
CirclFi's Value Trap algorithm assigns PGEN a score of 46/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
4 of 13 models are active for Precigen, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Precigen, Inc. earns a quality score of 4.4/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.
The gap between the most bullish and bearish model spans +105.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every PGEN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across PGEN's 4 active models, average confidence is 31%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad